Joel R Garbow Selected Research

Neoplasms (Cancer)

7/2023	Deuterium Magnetic Resonance Spectroscopy Quantifies Tumor Fraction in a Mouse Model of a Mixed Radiation Necrosis / GL261-Glioblastoma Lesion.
10/2022	Selective Cell Size MRI Differentiates Brain Tumors from Radiation Necrosis.
1/2022	Distinguishing Tumor Admixed in a Radiation Necrosis (RN) Background: 1H and 2H MR With a Novel Mouse Brain-Tumor/RN Model.
12/2021	Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia.
5/2021	Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents.
1/2021	Irradiation-Modulated Murine Brain Microenvironment Enhances GL261-Tumor Growth and Inhibits Anti-PD-L1 Immunotherapy.
11/2020	Radiolabeled 6-(2, 3-Dichlorophenyl)-N4-methylpyrimidine-2, 4-diamine (TH287): A Potential Radiotracer for Measuring and Imaging MTH1.
1/2020	Alteration of Cellular Reduction Potential Will Change 64Cu-ATSM Signal With or Without Hypoxia.
1/2019	Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapy.
1/2019	Late Effects of Radiation Prime the Brain Microenvironment for Accelerated Tumor Growth.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel R Garbow Research Topics

Disease

34	Neoplasms (Cancer) 07/2023 - 01/2002
14	Necrosis 07/2023 - 10/2009
7	Glioma (Gliomas) 12/2021 - 02/2007
6	Status Epilepticus (Complex Partial Status Epilepticus) 03/2024 - 01/2017
6	Brain Injuries (Brain Injury) 03/2024 - 01/2017
6	Brain Neoplasms (Brain Tumor) 10/2022 - 07/2013
6	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2013
6	Hypoxia (Hypoxemia) 01/2020 - 01/2015
4	Neuroinflammatory Diseases 03/2024 - 01/2017
4	Seizures (Absence Seizure) 03/2024 - 01/2017
4	Optic Nerve Glioma 12/2021 - 05/2007
4	Inflammation (Inflammations) 01/2020 - 06/2011
4	Cognitive Dysfunction 01/2019 - 01/2016
3	Hemorrhage 01/2021 - 05/2014
3	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2004
3	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2004
2	Atrophy 03/2024 - 01/2017
2	Intellectual Disability (Idiocy) 11/2023 - 02/2023
2	Autistic Disorder (Autism) 11/2023 - 02/2023
2	Edema (Dropsy) 10/2022 - 05/2014
2	Telangiectasis (Telangiectasia) 07/2014 - 05/2014
2	Adenocarcinoma of Lung 09/2013 - 08/2008
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 04/2024
1	Poisoning 03/2024
1	Autism Spectrum Disorder 02/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Asthma (Bronchial Asthma) 12/2021
1	Gliosis 01/2020
1	Ischemia 01/2020
1	Radiation Injuries (Radiation Sickness) 07/2018
1	Colitis 03/2018

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2005
7	OrganophosphatesIBA 03/2024 - 01/2017
6	Isoflurophate (DFP)FDA Link 03/2024 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 06/2011
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 10/2009
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 05/2014
3	Hematoxylin (Haematoxylon)IBA 01/2019 - 05/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2014
3	LigandsIBA 01/2013 - 12/2004
2	Nerve AgentsIBA 03/2024 - 01/2017
2	Midazolam (Versed)FDA LinkGeneric 03/2024 - 12/2021
2	Oxytocin (Pitocin)FDA LinkGeneric 02/2024 - 01/2020
2	MethyltransferasesIBA 11/2023 - 02/2023
2	DeuteriumIBA 07/2023 - 01/2022
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2016
2	CytokinesIBA 01/2019 - 01/2018
2	Amino Acids FDA Link 07/2018 - 07/2013
2	Chemokine ReceptorsIBA 01/2018 - 12/2004
2	plerixafor FDA Link 01/2018 - 12/2004
2	AntibodiesIBA 01/2017 - 05/2014
2	Oxygen (Dioxygen)IBA 01/2016 - 01/2015
2	Bevacizumab (Avastin)FDA Link 11/2015 - 05/2014
2	Peptides (Polypeptides)IBA 05/2009 - 10/2003
2	CarcinogensIBA 03/2008 - 04/2004
2	ManganeseIBA 03/2008 - 05/2007
1	Diazepam (Valium)FDA LinkGeneric 03/2024
1	BenzodiazepinesIBA 03/2024
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2024
1	Cholinergic Agents (Cholinergics)IBA 03/2024
1	DNA Methyltransferase 3AIBA 11/2023
1	A-Form DNA (A-DNA)IBA 11/2023
1	DNA (Deoxyribonucleic Acid)IBA 02/2023
1	Aquaporins (Water Channels)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	HydrogenIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Aquaporin 4IBA 01/2022
1	MitogensIBA 12/2021
1	DecorinIBA 12/2021
1	OvalbuminIBA 12/2021
1	tetramethylenedisulfotetramine (DSTA)IBA 12/2021
1	talazoparibIBA 05/2021
1	TritiumIBA 11/2020
1	Purine NucleosidesIBA 11/2020
1	Nudix HydrolasesIBA 11/2020
1	Connexin 43 (Connexin43)IBA 01/2020
1	beta-lapachoneIBA 01/2020
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 01/2020
1	NADP (NADPH)IBA 01/2020
1	2- (6- chloro- 2- (4- (3- fluoropropoxy)phenyl)imidazo(1,2- a)pyridin- 3- yl)- N,N- diethylacetamideIBA 01/2019
1	Proteasome InhibitorsIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2018
1	PolymersIBA 03/2018
1	Dextrans (Dextran)FDA Link 03/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2018

Therapy/Procedure

22	Therapeutics 03/2024 - 01/2002
7	Radiotherapy 10/2022 - 10/2015
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2007
3	Chemoprevention 10/2009 - 08/2008
2	Cranial Irradiation 10/2015 - 10/2009
2	Lung Transplantation 01/2009 - 12/2007
1	Enzyme Replacement Therapy 04/2024
1	Induced Labor 02/2024
1	Immunotherapy 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Extracorporeal Membrane Oxygenation 06/2018